https://sciex.com/content/SCIEX/na/us/en


5 Ways That SelexION Technology Will Address Your Biggest Analytical Challenges

Oct 3, 2017 | Blogs, Technology | 0 comments

If you are a scientist working with complex assays, finding a way to significantly improve selectivity of detection could solve some of your biggest analytical headaches. Are we right? If so, then you are in the right place.

If you are confronted with assay selectivity challenges, then explore the SelexION® Differential Mobility Spectrometry (DMS) technology.  SelexION technology delivers analyte separation that is orthogonal to mass separation, helping you to achieve a more selective MS assay, without returning to method development and complex sample preparation strategies.

If this is the first time you have read about the SelexION device, we suggest you also read the previous blog in this series where we introduced the ‘Science Behind SelexION DMS Technology’. Before you click on the link, keep reading to find out the top five ways that SelexION addresses your biggest analytical challenges.  

  1. Detection Challenges due to Matrix Interferences? SelexION technology can separate analyte ions from overlapping matrix interferences within complex samples, allowing for more selective detection of your compound of interest and worry-free quantitation.
  2. Inability to Confidently Separate Isobaric and Isomeric Species? SelexION technology addresses isobaric interferences by separating your sample prior to MS analysis to improve identification, such as separating phospholipid samples into sub-classes for accurate lipid class quantitation or identifying differentially localized modifications on the same peptide sequence.
  3. Quantitation Limits Hindered by High Background Noise? SelexION technology can reduce or remove background noise signal using the separation power of DMS, allowing your compound of interest to be detected at lower levels than previously possible.
  4. Lengthy Sample Preparation Procedures? If you’re required to perform lengthy and complex sample preparation procedures and HPLC conditions to separate your analyte of interest from interfering sample matrix components, simplify your prep procedures and rely on DMS orthogonal separation to reduce background and isolate your compound of interest prior to MS detection.
  5. Looking to Increase Assay Diversity without Decreasing Throughput? Unlike other differential ion mobility approaches, the SelexION DMS device is not permanent. It takes less than 2 minutes to install without breaking vacuum on your system. This means you can use SelexION for your challenging assays, and remove it when it’s not required with minimal impact to your instrument uptime.

Overcome these five common challenges and achieve a new dimension in selectivity by incorporating SelexION DMS separation on your SCIEX Triple Quad™, QTRAP®, or TripleTOF® System.

Questions and answers to help improve your mycotoxin analysis

During a recent webinar I shared method details for mycotoxin analysis on the SCIEX 7500 system. In this blog i will share the Q&A for the submitted questions that we did not have chance to answer during the live webinar.

A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial